標(biāo)題: Titlebook: Hands- On Liferay DXP; Learn Portlet Develo Apoorva Prakash,Shaik Inthiyaz Basha Book 2022 Apoorva Prakash and Shaik Inthiyaz Basha 2022 Li [打印本頁] 作者: 多愁善感 時(shí)間: 2025-3-21 18:52
書目名稱Hands- On Liferay DXP影響因子(影響力)
書目名稱Hands- On Liferay DXP影響因子(影響力)學(xué)科排名
書目名稱Hands- On Liferay DXP網(wǎng)絡(luò)公開度
書目名稱Hands- On Liferay DXP網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Hands- On Liferay DXP被引頻次
書目名稱Hands- On Liferay DXP被引頻次學(xué)科排名
書目名稱Hands- On Liferay DXP年度引用
書目名稱Hands- On Liferay DXP年度引用學(xué)科排名
書目名稱Hands- On Liferay DXP讀者反饋
書目名稱Hands- On Liferay DXP讀者反饋學(xué)科排名
作者: syncope 時(shí)間: 2025-3-21 23:12
Apoorva Prakash,Shaik Inthiyaz Bashaapproaches, and development of resistance. The particular challenges involved in translating these data to clinical application are discussed. .This volume should be of broad general interest to researchers and clinicians involved in cancer therapy as well as other scientists interested in current s作者: 控訴 時(shí)間: 2025-3-22 01:34 作者: 牽連 時(shí)間: 2025-3-22 07:34
Apoorva Prakash,Shaik Inthiyaz Bashacussed. .This volume should be of broad general interest to researchers and clinicians involved in cancer therapy as well as other scientists interested in current s978-3-7643-7414-3Series ISSN 0071-786X Series E-ISSN 2297-4555 作者: CURL 時(shí)間: 2025-3-22 11:27 作者: Provenance 時(shí)間: 2025-3-22 14:33 作者: abject 時(shí)間: 2025-3-22 19:45
Portlet Module Development, Liferay provides to maximize the utilization of the framework. LiferayMVC is the most implemented portlet type and provides a lot of flexibility to developers. In this chapter, you get some hands-on experience with portlet development basics.作者: Mosaic 時(shí)間: 2025-3-22 23:29 作者: 漫步 時(shí)間: 2025-3-23 03:29 作者: 有花 時(shí)間: 2025-3-23 08:33
, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate of cancer. In our opinion, the contribution of these agents will be tremendous.作者: Mosaic 時(shí)間: 2025-3-23 13:24 作者: 錯誤 時(shí)間: 2025-3-23 16:34 作者: BLAZE 時(shí)間: 2025-3-23 21:45 作者: 熟練 時(shí)間: 2025-3-24 01:29
, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate of cancer. In our opinion, the contribution of these agents will be tremendous.作者: peritonitis 時(shí)間: 2025-3-24 05:27 作者: BALE 時(shí)間: 2025-3-24 10:35 作者: Congregate 時(shí)間: 2025-3-24 14:27
Apoorva Prakash,Shaik Inthiyaz BashaDetailed coverage of Portlet module development in Liferay DXP.Explanation of Liferay DXP default behavior customization.Inclusion of advance concepts such as IPC, Message Bus etc作者: 柔聲地說 時(shí)間: 2025-3-24 16:33 作者: FLIT 時(shí)間: 2025-3-24 21:42 作者: LAST 時(shí)間: 2025-3-25 02:37 作者: Cerumen 時(shí)間: 2025-3-25 06:57
https://doi.org/10.1007/978-1-4842-8563-3Liferay; Liferay Portal; Liferay DXP Portal; Liferay Portlet; Liferay MVC Portlet; Liferay DXP Customizat作者: 周興旺 時(shí)間: 2025-3-25 08:28
978-1-4842-8562-6Apoorva Prakash and Shaik Inthiyaz Basha 2022作者: 一再困擾 時(shí)間: 2025-3-25 15:38
s or classic chemotherapy, there is no longer doubt that anti-angiogenic agents have become part of anticancer therapy in general. In the coming years, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate作者: Habituate 時(shí)間: 2025-3-25 18:54
Apoorva Prakash,Shaik Inthiyaz Bashas or classic chemotherapy, there is no longer doubt that anti-angiogenic agents have become part of anticancer therapy in general. In the coming years, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate作者: 來就得意 時(shí)間: 2025-3-25 20:21
Apoorva Prakash,Shaik Inthiyaz Bashacal application.There have been tremendous advances in our understanding of molecular and tumor biology during the past few years. In the field of cancer therapeutics, it is expected that cytotoxic drug approaches will be gradually replaced with treatments based on biological targeted approaches. Ho作者: 笨拙處理 時(shí)間: 2025-3-26 02:19
Apoorva Prakash,Shaik Inthiyaz Bashas, it is expected that cytotoxic drug approaches will be gradually replaced with treatments based on biological targeted approaches. Hopefully these new targeted therapies will significantly increase efficacy and lack the devastating and troublesome side effects elicited by cytotoxic chemotherapy...作者: glowing 時(shí)間: 2025-3-26 04:49 作者: foodstuff 時(shí)間: 2025-3-26 08:41 作者: 拔出 時(shí)間: 2025-3-26 16:09
Apoorva Prakash,Shaik Inthiyaz Bashas or classic chemotherapy, there is no longer doubt that anti-angiogenic agents have become part of anticancer therapy in general. In the coming years, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate作者: 官僚統(tǒng)治 時(shí)間: 2025-3-26 19:04 作者: 夾克怕包裹 時(shí)間: 2025-3-27 00:01 作者: Latency 時(shí)間: 2025-3-27 01:35
Liferay Development Basics,ronments and its fundamentals for creating, building, and deploying Liferay modules using different approaches, such as the wizard and the Blade CLI. The chapter also explains how to build modules using Gradle and Maven. Once you are familiar with these fundamentals, you learn how to start the Lifer作者: 真 時(shí)間: 2025-3-27 06:00
Portlet Module Development,portal. The Liferay portlet enables you to utilize features defined in the portlet specifications, and the cherries on top are the additional features Liferay provides to maximize the utilization of the framework. LiferayMVC is the most implemented portlet type and provides a lot of flexibility to d作者: 交響樂 時(shí)間: 2025-3-27 12:18 作者: 皮薩 時(shí)間: 2025-3-27 14:26
Service Builder Concepts,a master file. A lot of boilerplate code is generated when services are built using this file. This file helps generate the mappings. In this chapter, you learn everything about this process and the different ways to fetch data from the database.作者: humectant 時(shí)間: 2025-3-27 19:23
Liferay Customization, footers so they have a project-specific look and feel. But what if you have an out-of-box Liferay DXP portlet that matches your requirements, and a minor tweak can make it serve your project-specific business needs? What should you do in that case? To address this scenario, Liferay DXP provides an 作者: 高調(diào) 時(shí)間: 2025-3-28 00:59
Textbook 2009Latest editionacts and gives the reader an excellent insight into current research fields. A compilation of review problems makes the book especially valuable to both students and teachers. The new edition offers an additional chapter on the interaction of light and matter, plus end-of-chapter problems and solutions.作者: 加花粗鄙人 時(shí)間: 2025-3-28 02:20
Machteld Huber MD, PhD.,Hans Peter Jung MD, PhD.,Karolien van den Brekel-Dijkstra MD, PhD. be addressed within the quasispecies framework. Our hope is that at least some of the approaches we review in this text can be of help for anyone embarking on further analysis of the quasispecies model.
